Evidence map›Paper›PMID 37962552›Full record

ArticleJournal of clinical microbiology2023

Interlaboratory comparison of

Krupa Parmar, Lauren Komarow, Damon W Ellison, Andrey A Filippov, Mikeljon P Nikolich, Joseph R Fackler, Martin Lee, Anjna Nair, Priyesh Agrawal, Pranita D Tamma and 6 more

Open access · hybridAbstract read
In one paragraph

Article in Journal of clinical microbiology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 1 pooled it
3.0field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 1 synthesis or guideline pooled it, 12 citations in OpenAlex.

  1. Guideline
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Systematic bacteriophage selection for the lysis of multipleFrontiers in cellular and infection microbiology · 2025
    Article
  9. Review
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 6 institutions in 1 country.

Krupa ParmarDivision of Clinical Microbiology, Department of Laboratory Medicine and Pathology, Mayo Clinic , Rochester, Minnesota, USA.ORCID 0000-0003-2825-7185
Lauren KomarowBiostatistics Center, George Washington University , Rockville, Maryland, USA.
Damon W EllisonWound Infections Department, Bacterial Diseases Branch, Walter Reed Army Institute of Research , Silver Spring, Maryland, USA.
Andrey A FilippovWound Infections Department, Bacterial Diseases Branch, Walter Reed Army Institute of Research , Silver Spring, Maryland, USA.ORCID 0000-0003-2256-861X
Mikeljon P NikolichWound Infections Department, Bacterial Diseases Branch, Walter Reed Army Institute of Research , Silver Spring, Maryland, USA.ORCID 0000-0001-5770-8980
Joseph R FacklerAdaptive Phage Therapeutics Inc. , Gaithersburg, Maryland, USA.
Martin LeeAdaptive Phage Therapeutics Inc. , Gaithersburg, Maryland, USA.ORCID 0000-0002-0356-8844
Anjna NairAdaptive Phage Therapeutics Inc. , Gaithersburg, Maryland, USA.
Priyesh AgrawalAdaptive Phage Therapeutics Inc. , Gaithersburg, Maryland, USA.
Pranita D TammaDivision of Pediatric Infectious Diseases, Department of Pediatrics, Johns Hopkins University School of Medicine , Baltimore, Maryland, USA.ORCID 0000-0002-4143-6324
Maria SouliDuke Clinical Research Institute , Durham, North Carolina, USA.ORCID 0000-0003-3401-4534
Scott R EvansBiostatistics Center, George Washington University , Rockville, Maryland, USA.
Kerryl E Greenwood-QuaintanceDivision of Clinical Microbiology, Department of Laboratory Medicine and Pathology, Mayo Clinic , Rochester, Minnesota, USA.ORCID 0000-0003-3760-4310
Scott A CunninghamDivision of Clinical Microbiology, Department of Laboratory Medicine and Pathology, Mayo Clinic , Rochester, Minnesota, USA.ORCID 0000-0002-7589-1712
Robin PatelDivision of Clinical Microbiology, Department of Laboratory Medicine and Pathology, Mayo Clinic , Rochester, Minnesota, USA.ORCID 0000-0001-6344-4141
Antibacterial Resistance Leadership Group
Mayo Clinic · USWalter Reed Army Institute of Research · USClinical Research Institute · USGeorge Washington University · USJohns Hopkins University · USMilken Institute · US

Funding

Antibacterial Resistance Leadership Group (ARLG)UM1AI104681 · NIAID · DUKE UNIVERSITY · PI Vance G. Fowler, Henry F HENRY CHAMBERS · 2013 to 2026
$180.8M
NIAID NIH HHS UM1 AI104681
6 · The paper itself

Abstract

Standardized approaches to phage susceptibility testing (PST) are essential to inform selection of phages for study in patients with bacterial infections. There is no reference standard for assessing bacterial susceptibility to phage. We compared agreement between PST performed at three centers: two centers using a liquid assay standardized between the sites with the third, a plaque assay. Four

Indexed as

BacteriophagesCystic FibrosisPseudomonas InfectionsAnti-Bacterial AgentsHumansPseudomonas aeruginosaReproducibility of ResultsAnti-Bacterial Agentsliquid assayphage susceptibility testingplaque assayPseudomonas aeruginosa

Identifiers

PMID37962552
PMCPMC10729752
OpenAlexW4388672199

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.